Whittier Trust Co. of Nevada Inc. Purchases 1,145 Shares of CVS Health Corporation (NYSE:CVS)
Whittier Trust Co. of Nevada Inc. boosted its position in shares of CVS Health Corporation (NYSE:CVS) by 1.8% during the second quarter, Holdings Channel reports. The fund owned 63,116 shares of the pharmacy operator’s stock after buying an additional 1,145 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in CVS Health Corporation were worth $5,079,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. LSV Asset Management raised its position in CVS Health Corporation by 44.2% in the first quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock valued at $359,523,000 after buying an additional 1,404,384 shares in the last quarter. NN Investment Partners Holdings N.V. raised its position in CVS Health Corporation by 141.2% in the second quarter. NN Investment Partners Holdings N.V. now owns 1,427,210 shares of the pharmacy operator’s stock valued at $114,832,000 after buying an additional 835,476 shares in the last quarter. Swiss National Bank raised its position in CVS Health Corporation by 26.9% in the first quarter. Swiss National Bank now owns 3,826,410 shares of the pharmacy operator’s stock valued at $300,373,000 after buying an additional 811,100 shares in the last quarter. Karp Capital Management Corp bought a new position in CVS Health Corporation during the first quarter valued at about $55,824,000. Finally, Thornburg Investment Management Inc. raised its position in CVS Health Corporation by 31.8% in the first quarter. Thornburg Investment Management Inc. now owns 2,712,089 shares of the pharmacy operator’s stock valued at $212,899,000 after buying an additional 654,058 shares in the last quarter. Hedge funds and other institutional investors own 81.92% of the company’s stock.
CVS Health Corporation (CVS) traded up 0.34% during mid-day trading on Friday, hitting $79.41. The company’s stock had a trading volume of 2,985,502 shares. The firm has a market cap of $80.73 billion, a price-to-earnings ratio of 15.82 and a beta of 0.91. The firm has a 50 day moving average of $78.83 and a 200-day moving average of $78.96. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $98.44.
CVS Health Corporation (NYSE:CVS) last issued its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.32 earnings per share. On average, equities research analysts expect that CVS Health Corporation will post $5.88 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.00 dividend on an annualized basis and a yield of 2.52%. CVS Health Corporation’s dividend payout ratio (DPR) is currently 39.92%.
Several research analysts have recently issued reports on the company. BidaskClub upgraded CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC restated a “hold” rating and issued a $82.00 price target on shares of CVS Health Corporation in a research report on Friday, June 9th. ValuEngine lowered CVS Health Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Vetr upgraded CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $88.97 price target on the stock in a research report on Tuesday, June 6th. Finally, Cowen and Company restated an “outperform” rating and issued a $86.00 price target on shares of CVS Health Corporation in a research report on Tuesday, June 13th. Eight research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $91.27.
In other CVS Health Corporation news, EVP Helena Foulkes sold 20,333 shares of the company’s stock in a transaction on Monday, June 26th. The shares were sold at an average price of $80.00, for a total transaction of $1,626,640.00. Following the sale, the executive vice president now owns 59,301 shares of the company’s stock, valued at $4,744,080. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO David M. Denton sold 230,510 shares of the stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the transaction, the chief financial officer now directly owns 176,983 shares in the company, valued at approximately $14,158,640. The disclosure for this sale can be found here. Insiders have sold 271,175 shares of company stock worth $21,632,597 in the last ninety days. Insiders own 0.61% of the company’s stock.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.